Background and purpose: Recent studies have shown that resveratrol increased endothelial progenitor cells (EPCs) numbers and functional activity. However, the mechanisms remain to be determined. Previous studies have demonstrated that increased EPC numbers and activity were associated with the inhibition of EPC senescence, which involves activation of telomerase. Therefore, we investigated whether resveratrol inhibits the onset of EPC senescence through telomerase activation, leading to potentiation of cellular activity. Experimental approach: After prolonged in vitro cultivation, EPCs were incubated with or without resveratrol. The senescence of EPCs were determined by acidic b-galactosidase staining. The bromo-deoxyuridine incorporation assay or a modified Boyden chamber assay were employed to assess proliferative or migratory capacity, respectively. To further examine the underlying mechanisms of these effects, we measured telomerase activity and the phosphorylation of Akt by western blotting. Key results: Resveratrol dose dependently prevented the onset of EPCs senescence and increased the proliferation and migration of EPCs. The effect of resveratrol on senescence could not be abolished by eNOS inhibitor or by an oestrogenic receptor antagonist. Resveratrol significantly increased telomerase activity and Akt phosphorylation. Pre-treatment with the PI3K inhibitor, LY294002, significantly attenuated resveratrol-induced telomerase activity.
Introduction
Despite accumulating evidence demonstrating that endothelial progenitor cells (EPCs) are important in the maintenance of the endothelium, being implicated in both re-endothelialization and neovascularization (Asahara et al., 1997; Takahashi et al., 1999; Kawamoto et al., 2001; Kocher et al., 2001; Walter et al., 2002; Hill et al., 2003) , EPCs appear to be very susceptible to the impairment caused by cardiovascular pathogenic factors, such as oxidized low-density lipoprotein (oxLDL) (Imanishi et al., 2004) , homocystine (Chen et al., 2004) and angiotensin-II (Imanishi et al., 2005a) . Moreover, the decrease and dysfunction of EPCs has been observed in patients with coronary arterial disease (CAD), hypertension and diabetes (Vasa et al., 2001) . On the other hand, ex vivo culture of primary cells leads to cellular aging (senescence), thereby severely limiting the proliferative and migratory capacity that is useful for cell therapy of ischaemic disease. So the positive modulation of EPC levels is of particular clinical interest.
Resveratrol (trans-3,5,4 0 -trihydroxystilbene), a polyphenol phytoalexin, possesses diverse biochemical and physiological actions, including cardioprotective (Ray et al., 1999; Orallo et al., 2002) , oestrogenic (Gehm et al.,1997; Klinge et al., 2003) , antiplatelet (Pace-Asciak et al., 1995; Wang et al., 2002) and anti-inflammatory properties (Pendurthi et al., 1999; Shigematsu et al., 2003) . The richest source of resveratrol is the root of Polygonum cuspidatum, mainly cultivated in China and Japan. The skins of grapes contain about 50-100 mg g À1 resveratrol, and this is believed to be responsible for the cardioprotective properties of red wine (Orallo et al., 2002) , which contains 0.2-7 mg L À1 of wine. Recently, a few studies have documented that resveratrol dose and time dependently increased EPC numbers and enhanced cell proliferation, migration, adhesion, and their in vitro vasculogenic capacity (Gu et al., 2006; Wang et al., 2007a; Balestrieri et al., 2008) . However, the precise mechanisms by which resveratrol increased EPC numbers and activity remain to be determined. Studies have demonstrated that EPC senescence was associated with EPC numbers and activity (Assmus et al., 2003; Imanishi et al., 2004) . Cellular aging or senescence is characterized by cell-cycle arrest and can be triggered by different pathways (Greider, 1990) . Loss of telomerase activity has been suggested to constitute the molecular clock that triggers cellular senescence (Xu et al., 2000) . Murasawa et al. (2002) have demonstrated that overexpression of human telomerase reverse transcriptase by adenovirus-mediated gene delivery could result in a delay of senescence and a recovery or enhancement of the regenerative properties of EPCs. Furthermore, oxLDL has been shown to accelerate the senescence of EPCs by the inactivation of telomerase (Imanishi et al., 2004) .
On the basis of these considerations, we investigated whether resveratrol would prevent the onset of EPC senescence through telomerase activation, leading to potentiation of cellular activity. In the present study, we have demonstrated that resveratrol prevented the onset of EPC senescence, leading to potentiation of cellular activity. Moreover, resveratrol significantly increased telomerase activity and the phosphorylation of the serine-threonine kinase, Akt.
Materials and methods
Isolation, cultivation and characterization of circulating EPCs Informed consent was obtained from all volunteers and all the procedures were performed in accordance with national and international laws and policies. EPCs were isolated, cultured and characterized according to previously described techniques (Vasa et al., 2001; Chen et al., 2004; Seeger et al., 2005; Wang et al., 2007b) . Briefly, mononuclear cells (MNCs) were obtained from healthy human volunteers; all six volunteers (three male and three female; ages from 24 to 33 years with a median of 28 years) had no risk factors for CAD, including hypertension, diabetes, smoking, a positive family history of premature CAD and hypercholesterolemia and were free of wounds, ulcers, retinopathy, recent surgery, inflammation, malignant diseases or medications that might influence EPCs kinetics. MNCs were isolated from peripheral blood by Ficoll density gradient centrifugation and cultured on fibronectin-coated dishes in Medium 199 supplemented with 20% foetal-calf serum and vascular endothelial growth factor (VEGF, 50 ng mL À1 ). After 4 days of culture, non-adherent cells were removed by washing with phosphate-buffered saline (PBS), new medium was applied and the culture was maintained through 7 days. EPCs were characterized as adherent cells double positive for dioctadecyl-3,3,3 0 ,3 0 -tetramethylindocarbocyanine (DiI)-labelled acetylated low-density lipoprotein (acLDL) uptake and fluorescein isothiocyanate (FITC)-labelled Ulex europaeus agglutinin (UEA-1) binding under a laser scanning confocal microscope (LSCM). They were further documented by demonstrating the expression of VE-cadherin, VEGF receptor-2 (KDR/Flt-1), CD34, AC133 (also named CD133) and CD45 by flow cytometry.
Senescence-associated b-galactosidase activity assay Senescence-associated b-galactosidase (SA-b-gal) activity was measured with a b-galactosidase staining kit (BioVision, Palo Alto, CA, USA). The protocol was conducted according to the manufacturer's instructions. Briefly, EPCs at day 7 were treated with different concentration of resveratrol (10, 25 or 50 mM) separately for 3 more days. Then EPCs were washed in PBS, fixed for 10-15 min at room temperature with 0.5 mL of fixative solution, washed and incubated overnight at 371C with the staining solution mix. Cells were observed under a microscope for development of blue colour (total magnification Â 200) (Assmus et al., 2003; Imanishi et al., 2004) .
EPC proliferation assay EPC proliferation was assessed from the incorporation of 5-bromo-2 0 -deoxyuridine (BrdU). Briefly, isolated EPCs at day 10 were incubated in 96-well plastic plates (1 Â 10 4 cells per well) with BrdU (10 mM) for another 18 h. Subsequently, the cells were fixed and BrdU incorporation was determined with a Cell Proliferation ELISA Kit (Roche Diagnostics, Indianapolis, IN, USA), according to the manufacturer's instructions.
EPC migration assay
Migration of EPCs was evaluated using a modified Boyden chamber assay as previously described (Vasa et al., 2001) . Briefly, 5 Â 10 4 EPCs were placed in the upper chamber of a modified Boyden chamber (Qiling Medical Equipment Factory, Jiangsu, China). VEGF (50 ng mL
À1
) in serum-free M199 was placed in the lower compartment of the chamber. After 24 h incubation at 371, the lower side of the filter was washed with PBS and fixed with 2% paraformaldeyde. For quantification, cells were stained with Giemsa solution. Cells migrating into the lower chamber were counted manually in three random microscopic ( Â 200) fields.
Telomeric repeat-amplification protocol assay
To investigate the effect of resveratrol on telomerase activity, EPCs at day 7 were treated with different concentration of resveratrol (10, 25 or 50 mM) for 24 h, with or without pretreatment with LY294002 (10 mM). For quantitative analyses of telomerase activity, the telomeric repeat-amplification protocol assay, in which the telomerase reaction product is amplified by PCR (Kim and Wu, 1997) was performed using the TeloTAGGG PCR ELISA PLUS kit (Roche Molecular Biochemicals, Mannheim, Baden-Württemberg, Germany) according to the manufacturer's instructions.
Western blotting
The EPCs were treated with various concentrations of resveratrol for 24 h. They were then washed twice with PBS and lysed in ice-cold HNTG buffer (50 mM HEPES, 150 mM NaCl, 0.1% Triton X-100 and 10% glycerol). The lysates were centrifuged at 12 000 g (4 1C) for 20 min, and the protein concentrations of the supernatants were determined using the Bio-Rad (Hercules, CA, USA) protein assay. Equal amounts of proteins (50 mg) were separated on sodium dodecyl sulphate-polyacrylamide gel electrophoresis gels, as described previously (Benndorf et al., 2003) . After the separation, proteins were transferred to a nitrocellulose membrane (Amersham, Arlington Heights, IL, USA). Membranes were blocked by incubation in Tris-buffered saline (pH 7.5) containing 0.1% (v/v) Tween 20 and 5% (v/v) nonfat dry milk for 2 h, followed by 2 h of incubation at room temperature with rabbit polyclonal anti-phosphoAkt-Ser473 or anti-Akt antibodies. The filters were washed extensively in Tris-buffered saline containing 0.1% (v/v) Tween 20 before incubation for 1 h with a secondary anti-rabbit or anti-mouse antibody conjugated to horseradish peroxidase. Membranes were then washed and developed using the EZ-ECL Detection Kit (Biological Industries, Ashrat, Haifa, Israel).
Annexin-V-propidium iodide-binding assay
To determine whether or not resveratrol, over the range of concentrations studied, affected the apoptosis of EPCs, the apoptotic rate of EPCs was detected by the Annexin V-FITC Apoptosis Detection Kit (BioVision) according to the manufacturer's protocol. Briefly, after incubation with resveratrol of different concentrations separately for 3 days, 5 Â 10 6 isolated EPCs were resuspended in 500-mL-binding buffer. FITC-annexin V (5 mL) and propidium iodide (PI, 5 mL) working solution were added and then cells were incubated at room temperature for 5 min in the dark. After the incubation period, cells were analysed by flow cytometry, the annexin V-FITC binding was analysed by FITC signal detector (FL1) and PI staining by phycoerythrin emission signal detector (FL3). Apoptotic cells were identified as annexin V ( þ ) and PI (À).
Statistical analysis
Data are expressed as means ± s.d. from at least three independent experiments. Statistical analysis was performed by the two-tailed t-test or ANOVA for multiple comparisons. 
Nomenclature
The nomenclature of drug and molecular targets in this article follows the recommendations of the BJP's Guide to Receptors and Channels (Alexander et al., 2008) .
Results

Characterization of human EPCs
Total MNCs isolated and cultured for 7 days resulted in a spindle-shaped, endothelial cell-like morphology (Figure 1a ). EPCs were characterized as adherent cells positive for acLDL uptake and UEA-1 binding using LSCM (Figure 1b ). Cells were further identified by demonstrating the expression of KDR (82.1±6.4%), CD34 (29.0±5.7%), AC133 (19.1±4.8%), VE-cadherin (69.6 ± 6.4%) and CD45 (17.8 ± 4.0%; (Figure 1c ) by flow cytometry.
Resveratrol prevented EPC senescence
To assess the onset of senescence, acidic b-galactosidase was detected as a biochemical marker for acidification typical for the onset of cellular senescence (Greider, 1990; Dimri et al., 1995) . Cultivation of EPCs resulted in an increase in SA-bgal-positive cells after prolonged cultivation. As shown in Figure 2 , resveratrol influenced EPCs senescence dose dependently, with a maximal inhibitory effect achieved at 50 mM. However, an increase in senescence was observed at 100 mM, suggesting the cytotoxic effect of resveratrol at an extremely high concentration. To examine whether NO synthase was involved in the resveratrol-associated antisenescence effect, EPCs were pre-incubated with the selective NO sythase inhibitor-L-NAME (1 mM) 30 min before incubation with resveratrol at 50 mM. However, L-NAME failed to reverse the inhibitory effect of resveratrol. In addition, the oestrogen receptor (ER) antagonist ICI182780 (faslodex, 1 mM), which has no agonist properties, also did not alter the effect of resveratrol.
Effects of resveratrol on proliferation and migration of EPCs
Having demonstrated that resveratrol prevented the onset of senescence, we examined whether that would translate into 
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L Xia et al an increase of proliferation and migration. The BrdU incorporation assay demonstrated that the mitogenic potential of EPCs treated with resveratrol exceeded that in untreated (control) EPCs-an effect that was dose dependent (Figure 3a) . The modified Boyden chamber assay demonstrated that the migratory capacity of EPCs was also dose dependently increased by resveratrol (Figure 3b ).
Effects of resveratrol on telomerase activity in EPCs
Cellular senescence is critically influenced by telomerase, which elongates telomeres, thereby counteracting the reduction in telomere length induced by each cell division. Therefore, we measured telomerase activity in EPCs using the TeloTAGGG PCR ELISA PLUS kit. As demonstrated in Figure 4 , resveratrol dose dependently increased telomerase activity, with a maximal increase at 50 mM.
Resveratrol induced telomerase activity by the PI3K-Akt cascade
Recent studies have demonstrated that Akt is important in regulating cell senescence and telomerase activity (Kang et al., 1999; Breitschopf et al., 2001) . Moreover, Akt has been shown to be important in atorvastatin-mediated prevention of EPC senescence (Assmus et al., 2003) . To examine whether the PI3K-Akt cascade is involved in the resveratrol-induced telomerase activation, EPCs were pre-treated with the selective PI3K inhibitor-LY294002 (10 mM) 30 min before incubation with resveratrol. Interestingly, LY294002 clearly attenuated the increase in telomerase activity by resveratrol (Figure 4 ). We next investigated whether resveratrol would induce the phosphorylation of Akt, a downstream effector of PI3K. EPCs were stimulated with resveratrol at several concentrations for 24 h, and immunoblots were performed with anti-phospho-Akt (Ser
473
) or anti-Akt antibody. As shown in Figure 5 , stimulation with resveratrol led to dose-dependent phosphorylation of Akt, although it did not affect the total amount of Akt.
Effects of Resveratrol on apoptosis of EPCs
After the incubation period, apoptotic cells were evaluated by flow cytometry. Resveratrol at 50 mM had no obvious effect on EPC apoptosis. However, resveratrol at 100 mM significantly raised the apoptotic rate of cells, which is probably due to the cellular toxicity of resveratrol at high concentration ( Figure 6 ).
Discussion
Recent studies have provided increasing evidence that the functional regeneration of ischaemic tissue by improved neovascularization and tissue repair are critically dependent on the mobilization and integration of EPCs. Moreover, infusions of EPC populations that have been expanded ex vivo can limit the extension of scar tissue in ischaemic myocardium (Kawamoto et al., 2001) and improve the recovery of contractility, increase the arteriolar perfusion and decrease the pulmonary arterial pressure in pulmonary hypertension (Zhao et al., 2005; Wang et al., 2007b) , and thereby, may be useful as a novel therapeutic approach (Assmus et al., 2006) . However, several studies have indicated that aging or senescence may limit the ability of EPCs to sustain neovascularization and repair of ischaemic tissue (Vasa et al., 2001; Edelberg et al., 2002; Hill et al., 2003; Scheubel et al., 2003) , highlighting a potentially relevant feature of the endogenous repair process. This also posed an interesting question as to the value of therapies based on endogenous EPCs in either elderly patients or patients with atherosclerotic risk factors. Here, we have shown for the first time that resveratrol prevented the onset of EPC senescence, which was associated with a high proliferative and migrative capacity. However, resveratrol did not decrease the apoptosis of EPCs (Figure 6) .
A recent study (Assmus et al., 2003) has shown that EPC senescence was associated with a reduction of numbers and impairment of activity in the EPCs. In addition, the proatherosclerotic risk factor, oxLDL, accelerated the onset of EPC senescence, leading to cellular dysfunction (Imanishi et al., 2004) . Moreover, oestrogen has been shown to reduce EPC senescence, leading to the potentiation of proliferative activity and network formation (Imanishi et al., 2005b) . Keeping these findings in mind, we speculated that changes in EPC senescence, but not apoptosis of EPCs, might partly account for the mechanisms by which resveratrol increases EPC numbers and activity.
The mechanisms by which resveratrol prevents the onset of cellular senescence and increases the capacity of EPCs seem to involve telomerase activity. Telomerase, an RNAdirected DNA polymerase, extends telomeres of eukaryotic chromosomes and delays the development of senescence.
Recently, Murasawa et al. (2002) have revealed that overexpression of human telomerase reverse transcriptase (hTERT) by adenovirus-mediated gene delivery could result in a delay in senescence and recovery or enhancement of the regenerative properties of EPCs. In addition, oestrogen has been shown to significantly increase telomerase activity, which was considered to be associated with EPC senescence (Imanishi et al., 2005b) . Our data demonstrated that resveratrol dose dependently increased telomerase activity, suggesting that resveratrol at appropriate concentrations might prevent EPC senescence through activation of telomerase.
However, the molecular mechanisms by which resveratrol increased telomerase activity remains to be determined. In this study, we have shown that resveratrol significantly increased Akt phosphorylation. Previous studies have demonstrated that the serine-threonine kinase, Akt, enhanced telomerase activity through phosphorylation of TERT in human umbilical cord endothelial cells and melanoma cells (Kang et al., 1999; Breitschopf et al., 2001) . Besides the direct phosphorylation of TERT, Akt might also act against senescence by increasing the activity of the eNOS, as NO has been demonstrated to activate telomerase and delay endothelial-cell senescence (Vasa et al., 2000) . However, inhibition of the NO synthase by L-NAME did not reverse the inhibitory effect of resveratrol (Figure 1) , suggesting that the regulation of EPC senescence is independent of NO, which is in line with a previous report (Assmus et al., 2003) . Taken together, our data indicated that resveratrol increased Akt Resveratrol inhibits senescence in EPCs L Xia et al phosphorylation in EPCs, which might lead to increased phosphorylation of TERT and enhance telomerase activity, thereby preventing the onset of senescence in EPCs. However, inducing Akt phosphorylation would also mean that resveratrol could be influencing many other signal transduction mechanisms. Thus, the number of EPCs, in ex vivo cultures, could be reduced by the activation of p38 mitogen-activated protein kinase (MAPK) and this reduction was not caused by apoptosis (Seeger et al., 2005) . Moreover, inhibition of p38 significantly increased the proliferation of EPCs and reduced the numbers of cells expressing monocytic markers. Given the close links and complicated interaction between PI3K-Akt and ras-MAPK cascades in signal transduction networks, it is not possible to exclude the involvement of the p38 MAPK pathway in the effect of resveratrol on EPCs at present. In addition, the roles of relevant transcription factors that regulate cell-cycle control genes, such as cAMPresponsive element-binding protein and signal transducers and activators of transcription 3, which could be activated by MAPK or mammalian target of rapamycin remain to be further studied in future.
Resveratrol has been recognized as a phytoestrogen based on its structural similarities to diethylstilbestrol. It can bind to ERs to modulate the expression of oestrogen-regulated genes (Gehm et al., 1997; Klinge et al., 2003) . Recent studies have documented that oestrogen reduces EPC senescence by activating telomerase (Imanishi et al., 2005b) , so one might speculate that the inhibitory effect on EPC senescence was mediated by some oestrogenic property of resveratrol. However, in our study, the ER antagonist ICI182780 did not block the inhibitory effect of resveratrol, suggesting that the ERs were not involved in this effect of resveratrol. However, controversy about the oestrogenic behaviour of resveratrol is continuing. Ashby et al. (1999) showed that resveratrol possessed anti-oestrogen activity as it suppressed progesterone receptor expression induced by oestradiol. Moreover, most of the in vivo studies have failed to confirm the oestrogenic potential of resveratrol at physiological or even higher concentrations (Ashby et al., 1999; Freyberger et al., 2001) . Taking all these findings together, we consider that the anti-senescence effect of resveratrol is more likely to be unrelated to its oestrogenic properties.
In conclusion, the results of the present study demonstrate that resveratrol delays the onset of senescence in EPCs, which appears to be related to activation of telomerase and Akt phosphorylation. The inhibition of EPC senescence by resveratrol in vitro may improve the functional activity of EPCs in a way that is important for potential cell therapy.
